BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23866484)

  • 1. Evaluation of contributing factors of post transplant erythrocytosis in renal transplant patients.
    Ahmed S; Ahmed E; Naqvi R; Qureshi S
    J Pak Med Assoc; 2012 Dec; 62(12):1326-9. PubMed ID: 23866484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors predisposing to post-renal transplant erythrocytosis. A prospective matched-pair control study.
    Kessler M; Hestin D; Mayeux D; Mertes PM; Renoult E
    Clin Nephrol; 1996 Feb; 45(2):83-9. PubMed ID: 8846535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the angiotensin-converting enzyme inhibitor enalapril on post-transplant erythrocytosis.
    Marubayashi S; Yamamoto H; Shibata S; Fudaba Y; Miyata Y; Fukuma K; Okada K; Hinoi T; Ikeda M; Maeda T; Oshiro Y; Dohi K
    Hiroshima J Med Sci; 1998 Sep; 47(3):121-4. PubMed ID: 9810784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttransplant erythrocytosis in renal transplant recipients at Jeddah Kidney Center, Kingdom of Saudi Arabia.
    Basri N; Gendo MZ; Haider R; Abdullah KA; Hassan A; Shaheen FA
    Exp Clin Transplant; 2007 Jun; 5(1):607-9. PubMed ID: 17617052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of post-renal transplant erythrocytosis and microalbuminuria: response to angiotensin-converting enzyme inhibition.
    Mulhern JG; Lipkowitz GS; Braden GL; Madden RL; O'Shea MH; Harvilchuck H; Guarnera JM; Germain MJ
    Am J Nephrol; 1995; 15(4):318-22. PubMed ID: 7573190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predisposing to post-renal transplant erythrocytosis: a retrospective study.
    Charfeddine K; Zaghdane S; Yaich S; Hakim A; Hachicha J
    Saudi J Kidney Dis Transpl; 2008 May; 19(3):371-7. PubMed ID: 18445895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ramipril in post-renal transplant erythrocytosis.
    Esposito R; Giammarino A; De Blasio A; Martinelli V; Cirillo F; Scopacasa F; Federico S; Russo D
    J Nephrol; 2007; 20(1):57-62. PubMed ID: 17347974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibitor-induced anemia and treatment for erythrocytosis in renal transplant recipients.
    Satoh S; Kaneko T; Seino K; Abe T; Omori S; Sugimura J; Fujioka T; Kubo T
    Nihon Jinzo Gakkai Shi; 1995 Jun; 37(6):343-7. PubMed ID: 7666600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of angiotensin-converting enzyme polymorphism gene, IGF-1, and other factors in the response rate of hematocrit to enalapril treatment in patients with posttransplant erythrocytosis.
    Jimeno L; Rodado R; Barrios Y; Campos M; Llorente S; Nicolas F; Minguela A
    Transplant Proc; 2005 Mar; 37(2):1012-3. PubMed ID: 15848608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of enalapril on exaggerated erythropoietin response to phlebotomy in erythrocytosic renal transplant patients.
    Usalan C; Erdem Y; Cağlar M; Altun B; Arici M; Bakkaloğlu M; Yasavul U; Turgan C; Cağlar S
    Nephrol Dial Transplant; 1998 Nov; 13(11):2884-9. PubMed ID: 9829495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of post kidney transplantation erythrocytosis (PTE) with ACE inhibitors].
    Morale W; Puliatti C; Veroux P; Veroux M; Valvo C; Cappello D; Puliatti D; Francesco L
    Minerva Urol Nefrol; 2002 Sep; 54(3):189-92. PubMed ID: 12384621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term effects of ACE inhibitors on the erythrocytosis in renal transplant recipients.
    Lal SM; Trivedi HS; Ross G
    Int J Artif Organs; 1995 Jan; 18(1):13-6. PubMed ID: 7607751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-transplant erythrocytosis refractory to ACE inhibitors and angiotensin receptor blockers.
    Vishnu P; Moreno Vanegas Y; Wadei HM; Rivera CE
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29954763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of enalapril after ineffective theophylline treatment on erythrocytosis after renal transplantation.
    Yagisawa T; Toma H; Yaguchi H; Tomaru M; Iijima Y; Suzuki H; Nakada T
    Int Urol Nephrol; 1997; 29(3):363-7. PubMed ID: 9285312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin converting enzyme gene polymorphism and development of post-transplant erythrocytosis.
    Yildiz A; Yazici H; Cine N; Kazancioglu R; Akkaya V; Sever MS; Ark E; Erginel-Unaltuna N
    J Nephrol; 2003; 16(3):399-403. PubMed ID: 12832741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of erythrocytosis post renal transplantation.
    Razeghi E; Kaboli A; Pezeshki ML; Meysamie AP; Khatami MR; Khashayar P
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):559-63. PubMed ID: 18580013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-renal transplant erythrocytosis: a case report.
    Almonte M; Velásquez-Jones L; Valverde S; Carleton B; Medeiros M
    Pediatr Transplant; 2015 Feb; 19(1):E7-10. PubMed ID: 25418869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term therapy for postrenal transplant erythrocytosis with ACE inhibitors: efficacy, safety and action mechanisms.
    Montanaro D; Groupuzzo M; Boscutti G; Risaliti A; Bresadola F; Mioni G
    Clin Nephrol; 2000 Apr; 53(4):suppl 47-51. PubMed ID: 10809436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of post kidney transplantation erythrocytosis (PTE) with ACE inhibitors].
    Morale W; Puliatti C; Veroux P; Veroux M; Valvo C; Cappello D; Puliatti D; Francesco L
    Minerva Urol Nefrol; 2002 Jun; 54(2):145-8. PubMed ID: 12070465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplant erythrocytosis: a review of 47 renal transplant recipients.
    Abdelrahman M; Rafi A; Ghacha R; Qayyum T; Karkar A
    Saudi J Kidney Dis Transpl; 2004; 15(4):433-9. PubMed ID: 17642778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.